Search results
Syrian first lady Asma al-Assad diagnosed with leukemia, president's office says
Fox News via Yahoo News· 6 days agoAsma al-Assad will “adhere to a specialized treatment protocol that includes stringent infection...
Niclosamide combined to Azacitidine to target TP53-mutated MDS/AML cells - Leukemia
Nature· 5 days agoMyelodysplastic syndromes (MDS) are malignant bone marrow disorders characterized by ineffective hematopoiesis leading to refractory cytopenias and an increased risk of progression to
Recommendations from the AML molecular MRD expert advisory board - Leukemia
Nature· 4 days agoThe standard-of-care treatment for patients with acute myeloid leukemia (AML) is being challenged by new classes of ...
St. Jude patient's lifesaving story: 'I was losing my ability to function at that point'
ABC 13 Lynchburg· 5 days agoDoctors diagnosed Anna with acute myeloid leukemia, an aggressive form of the disease, when she was...
Rigel Announces Presentations at the Upcoming 2024 ASCO Annual Meeting and EHA2024 Hybrid Congress
WROC Rochester· 3 days agoOral presentation of final five-year results from the registrational Phase 2 trial in R/R mIDH1 AML patients reinforces REZLIDHIA® (olutasidenib) efficacy in heavily pretreated patients, including ...
Small Business - Salisbury Post | Salisbury Post
The Salisbury Post· 3 days agoASCO 2024 | Ascentage Pharma Releases Latest Results from Multiple Clinical Studies of Its Lead Drug Candidates PR Newswire SUZHOU, China and ROCKVILLE, Md., May 23, 2024 SUZHOU, China and ROCKVILLE, Md., May 23, 2024 /PRNewswire/ -- Ascentage Pharma
Syrian first lady diagnosed with leukemia
China Daily· 5 days agoSyrian First Lady Asma al-Assad has been diagnosed with acute myeloid leukemia, a type of blood cancer, the Syrian presidency said in ...
All over the body: Here are the key clinical trials from Bay Area firms - San Francisco Business...
The Business Journals· 2 days agoSince the turn of the millennium, Bay Area organizations and researchers have launched more than 300...
MD Anderson Research Highlights for May 21, 2024 | Newswise
Newswise· 6 days agoThe University of Texas MD Anderson Cancer Center’s Research Highlights showcases the latest breakthroughs in cancer care, research and prevention. These
NCI-MATCH Precision Medicine Clinical Trial
National Cancer Institute· 3 days agoNCI-MATCH, also known as MATCH, is a precision medicine cancer treatment clinical trial that sought to find out if treating cancer based on specific...